Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1967 Dec 23;4(5581):718–720. doi: 10.1136/bmj.4.5581.718

Fibrin degradation products in sera of normal subjects.

P C Das, A G Allan, D G Woodfield, J D Cash
PMCID: PMC1748968  PMID: 6060821

Full text

PDF
718

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization. J Clin Invest. 1962 Apr;41:917–934. doi: 10.1172/JCI104547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ASTRUP T. The biological significance of fibrinolysis. Lancet. 1956 Sep 15;271(6942):565–568. doi: 10.1016/s0140-6736(56)92048-7. [DOI] [PubMed] [Google Scholar]
  3. Blombäck B., Blombäck M., Edman P., Hessel B. Human fibrinopeptides. Isolation, characterization and structure. Biochim Biophys Acta. 1966 Feb 28;115(2):371–396. doi: 10.1016/0304-4165(66)90437-5. [DOI] [PubMed] [Google Scholar]
  4. Buluk K., Malofiejew M., Czokalo M. Unknown properties of the products of plasmin-degradation of fibrinogen and fibrin. Bull Acad Pol Sci Biol. 1966;14(4):193–197. [PubMed] [Google Scholar]
  5. Cash J. D. Effect of moderate exercise on the fibrinolytic system in normal young men and women. Br Med J. 1966 Aug 27;2(5512):502–506. doi: 10.1136/bmj.2.5512.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FERREIRA H. C., MURAT L. G. An immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states. Br J Haematol. 1963 Jul;9:299–310. doi: 10.1111/j.1365-2141.1963.tb06554.x. [DOI] [PubMed] [Google Scholar]
  7. Ferri R. G., Ferreira H. C. Immunochemical studies of the circulating products of fibrinogenolysis in certain pathological conditions. Vox Sang. 1963 May-Jun;8(3):356–362. [PubMed] [Google Scholar]
  8. GENTON E., KERN F., Jr, VON KAULLA K. Fibrinolysis induced by pressor amines. Am J Med. 1961 Oct;31:564–571. doi: 10.1016/0002-9343(61)90140-1. [DOI] [PubMed] [Google Scholar]
  9. IATRIDIS S. G., FERGUSON J. H. Effect of physical exercise on blood clotting and fibrinolysis. J Appl Physiol. 1963 Mar;18:337–344. doi: 10.1152/jappl.1963.18.2.337. [DOI] [PubMed] [Google Scholar]
  10. Jerushalmy Z., Zucker M. B. Some effects of fibrinogen degradation products (FDP) on blood platelets. Thromb Diath Haemorrh. 1966 May 15;15(3):413–419. [PubMed] [Google Scholar]
  11. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  12. NIEWIAROWSKI S., LATALLO Z., STACHURSKA J. Apparition d'un inhibiteur de la thromboplastinoformation au cours de la protéolyse du fibrinogène. Rev Hematol. 1959 Apr-Jun;14(2):118–128. [PubMed] [Google Scholar]
  13. NUSSENZWEIG V., SELIGMANN M., PELMONT J., GRABAR P. [The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties]. Ann Inst Pasteur (Paris) 1961 Mar;100:377–389. [PubMed] [Google Scholar]
  14. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES